Natco Pharma Approves Allotment of 1.71 Crore Equity Shares via Rights Issue
Natco Pharma Ltd · Others (Uncategorized) · 24 Oct 2026, 2:35 am
Natco Pharma Approves Allotment of 1.71 Crore Equity Shares via Rights Issue Natco Pharma Limited's Fund Raising Committee approved the allotment of 1,70,58,082 equity shares on 23rd Oct'26 pursuant to its rights issue. The shares were allotted at an issue price of ₹750 per share, including a premium of ₹748 per share against a face value of ₹2. Consequently, the company's paid-up equity share capital expanded from ₹35,82,19,740 (17,91,09,870 shares) to ₹39,23,35,904 comprising 19,61,67,952 fully paid-up equity shares.
Original exchange filing (PDF)
More announcements from Natco Pharma Ltd
- Intimation of Investor Meet · 17 Nov 2026
- Audio link of Earnings Conference Call Q2FY27 · 14 Nov 2026
- Q2 FY27 Earnings Presentation · 13 Nov 2026
- Un audited Financial Results for the quarter and half year ended 30th September, 2026 · 13 Nov 2026
- 19th November, 2026 is the Record Date for the payment of 2nd Interim Dividend for FY 2026-27 · 13 Nov 2026
- Natco Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026 and declaration of 2nd Interim Dividend for FY 2026-27 · 13 Nov 2026
- Outcome of Board Meeting · 13 Nov 2026
- Intimation of schedule of Concall · 13 Nov 2026
